VALYSTR · Stock research
Listed on NasdaqCM. What the market is pricing into 22nd Century Group, Inc. (XXII) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $46,981 · revenue $5.2M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows